Opendata, web and dolomites

LASER-HEAL

A breakthrough laser-based medical device to eradicate bacterial biofilm in chronic wounds and accelerate wound healing.

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 LASER-HEAL project word cloud

Explore the words cloud of the LASER-HEAL project. It provides you a very rough idea of what is the project "LASER-HEAL" about.

22    exit    silent    generating    data    approval    device    showing    laser    people    obtaining    optomechatronics    market    tackle    bacteria    compatible    willingness    treatment    eradicate    12    million    proposition    risked    invasive    software    first    sales    map    manner    solution    preferred    2017    killing    lack    pay    smei    game    protecting    delivering    safe    biofilms    29bn    rapid    72bn    commercialize    annual    bn    antibiofilm    heal    deep    contours    seek    informa    human    total    preliminary    acquisition    wound    cells    care    intact    company    truly    fda    time    standard    predicted    2024    epidemic    fast    gt    wounds    2025    mins    backed    clinics    markets    de    75    global    abstract    species    consists    confidential    cumulative    skin    changing    39bn    chronic    successful    left    commercial    recognize    confirm    solutions    10m    regulatory    medical    revenue    introduction    session    income    move   

Project "LASER-HEAL" data sheet

The following table provides information about the project.

Coordinator
VULCUR MEDTECH 

Organization address
address: SONDERVIGVEJ 50
city: VANLOSE
postcode: n.a.
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Denmark [DK]
 Project website http://vulcur.com/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-05-01   to  2019-10-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    VULCUR MEDTECH DK (VANLOSE) coordinator 50˙000.00

Map

 Project objective

Chronic wounds affect 10M in Europe and 6.4 million people in the US, with annual costs of >€72Bn in Europe and >€22 Bn in the US. It is a silent epidemic. Key to this problem is the lack of truly effective solutions that fully eradicate bacteria-protecting biofilms deep within chronic wounds.

We have a game-changing new solution to tackle this problem: LASER-HEAL. LASER-HEAL is a medical device that consists of 1) a laser-generating unit that can reach deep within wounds; 2) optomechatronics to move the laser in a controlled manner and 3) software to recognize the contours and depth of wounds. LASER-HEAL enables, for the first time, non-invasive, safe, low-cost (€1.000 p/treatment), rapid (30 mins/session, total ~12) treatment, compatible with standard of care. We have preliminary data showing killing of all relevant species of bacteria, while human skin cells are left intact.

We will bring LASER-HEAL to the global wound care management market (€29bn in 2017 expected to reach €39bn by 2024). We will respond to the need of this market by delivering an effective antibiofilm device for chronic wounds. We will commercialize LASER-HEAL through sales to US clinics first, through fast FDA approval and confirm willingness to pay. By 2025, we will demonstrate revenue potential for LASER-HEAL, and seek a commercial exit, through acquisition (preferred) by a major medical device company, who will then bring LASER-HEAL to the European and global markets. Cumulative income of €75 million is predicted for LASER-HEAL by 2025 during this phase.

We have a unique proposition, backed by preliminary results and the interest of a major wound care company (confidential for this abstract). We want to undertake a detailed study to map successful market introduction for LASER-HEAL. Funding from SMEi Phase can support us with obtaining crucial market, regulatory and de-risked development informa

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "LASER-HEAL" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "LASER-HEAL" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

MCBD (2019)

MCBD (MULTI-CORE BIOPSY DEVICE) INNOVATIVE BIOPSY TECHNOLOGY FOR THE NEW ERA OF TARGETED MEDICINE

Read More  

In-Heal (2019)

Standardised administration device for raw medical herbs

Read More  

ALICE (2019)

Armored Liftable anti-Intrusion Control Equipment

Read More